Seattle Archives

PCa Commentary | Volume 129 – December 2018

Posted by Edward Weber, MD | Dec 2018

PCa Commentary | Volume 129 – December 2018Posted by Edward Weber | December 2018THE AXUMIN...

PCa Commentary | Volume 128 – November 2018

Posted by Edward Weber, MD | Nov 2018

PCa Commentary | Volume 128 – November 2018Posted by Edward Weber | November...

Genomic Markers and DNA Sequencing Testing

Posted by Daniel W. Lin, MD | Oct 2018

Daniel W. Lin, MD, reviews novel and emerging biomarkers across the spectrum of prostate cancer. He then explains an emerging model of prostate cancer treatment with genomic markers and DNA sequencing, discussing newly-identified precision targets and their therapeutic decision-making utility.

PCa Commentary | Volume 127 – October 2018

Posted by Edward Weber, MD | Oct 2018

PCa Commentary | Volume 127 – October 2018 Posted by Edward Weber | October 2018 DECIPHER...

The Future of Genomic Markers and DNA Sequencing in Prostate Cancer

Posted by Daniel W. Lin, MD | Oct 2018

Daniel W. Lin, MD, discusses the future genomic markers and DNA sequencing in prostate cancer management. He explains DNA sequencing can ultimately improve cure rates when applied to advanced prostate cancer patients.